DISEASE INDICATIONS: Sickle Cell Disease
MANUFACTURER: Novartis
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Adakveo, with its active ingredient crizanlizumab, is a prescription medication used in the treatment of a specific medical condition known as sickle cell disease (SCD).
